Results 111 to 120 of about 5,677 (156)

[IgA vasculitis with necrosis of the small intestine secondary to monoclonal gammopathy of renal significance: A case report]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban
Ding Y   +7 more
europepmc   +1 more source

[Expert consensus on the comprehensive management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma in China (2025)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Plasma Cell Disease Group   +3 more
europepmc   +1 more source

3A1-柔红霉素对急性T细胞白血病的效果与安全性初探

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 1996
应用单克隆抗体3A1-柔红霉素结合物(3A1-DM)临床治疗8例急性T淋巴细胞白血病患者。经初步验证,鼠源性单克隆抗体制备的导向药物输入人体内未发生严重过敏反应与毒副作用。疗程完毕后,以骨髓象为标准评价临床治疗效果,获完全缓解者3/8例(37.5%),部分缓解4/8例(50%),无效1/8例(12.5%)例,总有效率达87.5%。初步验证了微量导向药物在临床治疗中的效果。
doaj  

131I-Anti-c-erb2 免疫导向治疗卵巢癌的实验研究

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2004
【目的】观察放射性核素标记针对癌蛋白为靶点的单克隆抗体载体外对卵巢癌细胞的抑制作用。【方法】应用氯胺T法将131I和抗c-erb2单克隆抗体标记,取不同浓度的131I-Anti-c-erb2与SKOV3细胞共同培养,MTT法检测其对SKOV3细胞生长的抑制作用。【结果】体外单抗浓度为22.20mg/L时,131I-Anti-c-erb2的相对抑制率为64.85%,可以明显抑制SKOV3细胞,未标记的抗c-erb2单抗的相对抑制率为3.40%,对SKOV3细胞的生长几乎没有抑制作用。【结论】131I ...
doaj  

[Clinical characteristics, treatment, and prognosis of double-hit multiple myeloma with concurrent 1q21+ and t (4;14)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Guo Y   +8 more
europepmc   +1 more source

[Advances in targeted therapies for chronic spontaneous urticaria]. [PDF]

open access: yesZhejiang Da Xue Xue Bao Yi Xue Ban
Zhou L, Hu C, Wang S, Zhang R.
europepmc   +1 more source

[Indolent γδT-cell clone in Felty syndrome: a case report and literature review]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Wang C, Fu MW, An G, Huang WY, Yang LJ.
europepmc   +1 more source

Home - About - Disclaimer - Privacy